View Future GrowthPhiChem 過去の業績過去 基準チェック /46PhiChemの収益は年間平均-5.6%の割合で減少していますが、 Chemicals業界の収益は年間 減少しています。収益は年間5.6% 6.1%割合で 増加しています。 PhiChemの自己資本利益率は8.1%であり、純利益率は12.1%です。主要情報-5.65%収益成長率-6.92%EPS成長率Chemicals 業界の成長12.10%収益成長率6.15%株主資本利益率8.07%ネット・マージン12.10%前回の決算情報31 Dec 2025最近の業績更新お知らせ • Mar 31PhiChem Corporation to Report Q1, 2026 Results on Apr 22, 2026PhiChem Corporation announced that they will report Q1, 2026 results on Apr 22, 2026お知らせ • Dec 31PhiChem Corporation to Report Fiscal Year 2025 Results on Apr 22, 2026PhiChem Corporation announced that they will report fiscal year 2025 results on Apr 22, 2026お知らせ • Sep 30PhiChem Corporation to Report Q3, 2025 Results on Oct 30, 2025PhiChem Corporation announced that they will report Q3, 2025 results on Oct 30, 2025お知らせ • Jul 02PhiChem Corporation to Report First Half, 2025 Results on Aug 28, 2025PhiChem Corporation announced that they will report first half, 2025 results on Aug 28, 2025お知らせ • Mar 31PhiChem Corporation to Report Q1, 2025 Results on Apr 23, 2025PhiChem Corporation announced that they will report Q1, 2025 results on Apr 23, 2025お知らせ • Dec 31PhiChem Corporation to Report Fiscal Year 2024 Results on Apr 23, 2025PhiChem Corporation announced that they will report fiscal year 2024 results on Apr 23, 2025すべての更新を表示Recent updatesValuation Update With 7 Day Price Move • Jun 08Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥41.23, the stock trades at a forward P/E ratio of 39x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 146% over the past three years.お知らせ • Apr 22PhiChem Corporation, Annual General Meeting, May 12, 2026PhiChem Corporation, Annual General Meeting, May 12, 2026, at 14:30 China Standard Time. Location: The Company's Meeting Room, Shanghai Chinaお知らせ • Mar 31PhiChem Corporation to Report Q1, 2026 Results on Apr 22, 2026PhiChem Corporation announced that they will report Q1, 2026 results on Apr 22, 2026お知らせ • Dec 31PhiChem Corporation to Report Fiscal Year 2025 Results on Apr 22, 2026PhiChem Corporation announced that they will report fiscal year 2025 results on Apr 22, 2026お知らせ • Sep 30PhiChem Corporation to Report Q3, 2025 Results on Oct 30, 2025PhiChem Corporation announced that they will report Q3, 2025 results on Oct 30, 2025お知らせ • Jul 02PhiChem Corporation to Report First Half, 2025 Results on Aug 28, 2025PhiChem Corporation announced that they will report first half, 2025 results on Aug 28, 2025お知らせ • May 22PhiChem Corporation Approves Cash Dividend for 2024PhiChem Corporation held its Annual General Meeting of 2024 on 16 May 2025, approved cash dividend/10 shares (tax included): CNY 0.65000000 for 2024.お知らせ • Apr 25PhiChem Corporation Proposes Final Cash Dividend for the Year 2024PhiChem Corporation proposed final cash dividend/10 shares (tax included) of CNY 0.65000000 for the year 2024.お知らせ • Apr 23PhiChem Corporation, Annual General Meeting, May 16, 2025PhiChem Corporation, Annual General Meeting, May 16, 2025, at 14:30 China Standard Time. Location: The Company's Meeting Room, Shanghai Chinaお知らせ • Mar 31PhiChem Corporation to Report Q1, 2025 Results on Apr 23, 2025PhiChem Corporation announced that they will report Q1, 2025 results on Apr 23, 2025お知らせ • Mar 22Shenmao Technology Inc (TWSE:3305) completed the acquisition of Profound Material Technology Co., Ltd. from PhiChem Corporation (SZSE:300398).Shenmao Technology Inc (TWSE:3305) signed a letter of intent to acquire Profound Material Technology Co., Ltd. from PhiChem Corporation (SZSE:300398) for approximately CNY 230 million on September 27, 2024. Profound Material Technology Co., Ltd. had reported total assets of CNY 127.176 million, total owner’s equity of CNY 99.815 million, revenue of CNY 99.6654 million, operating profit of CNY 13.1983 million and net profit of CNY 10.5306 million on December 31, 2023. The transaction is subject to approval of offer by acquirer board. The deal has been approved by the board of Shenmao Technology Inc. Transaction has been approved by PhiChem Corporation's Board of director's and is still subject to approval from PhiChem Corporation's shareholders. As on January 6, 2025, PhiChem Corporation and Shenmao Technology signed the Share Purchase and Sale Agreement. Transaction is expected to complete on March 20, 2025. Shenmao Technology Inc (TWSE:3305) completed the acquisition of Profound Material Technology Co., Ltd. from PhiChem Corporation (SZSE:300398) on March 20, 2025.お知らせ • Dec 31PhiChem Corporation to Report Fiscal Year 2024 Results on Apr 23, 2025PhiChem Corporation announced that they will report fiscal year 2024 results on Apr 23, 2025お知らせ • Dec 21PhiChem Corporation Announces Third Quarter 2024 Profit Distribution, Payable on 27 December 2024PhiChem Corporation announced 2024 third quarter profit distribution plan to be implemented (A shares): Cash dividend per 10 shares (tax included) of CNY 0.30000000. Record date: 26 December 2024; Ex-date: 27 December 2024; Payment date: 27 December 2024.お知らせ • Oct 30PhiChem Corporation Proposes Cash Dividend for the Third Quarter of 2024PhiChem Corporation announced on 29 October 2024 the profit distribution proposal for the third quarter of 2024 as follows: Cash dividend/10 shares (tax included) of CNY 0.30000000.Reported Earnings • Oct 29Third quarter 2024 earnings released: EPS: CN¥0.16 (vs CN¥0.069 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.16 (up from CN¥0.069 in 3Q 2023). Revenue: CN¥762.0m (up 7.5% from 3Q 2023). Net income: CN¥85.7m (up 138% from 3Q 2023). Profit margin: 11% (up from 5.1% in 3Q 2023). Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings.お知らせ • Sep 30PhiChem Corporation to Report Q3, 2024 Results on Oct 29, 2024PhiChem Corporation announced that they will report Q3, 2024 results on Oct 29, 2024Reported Earnings • Aug 30Second quarter 2024 earnings released: EPS: CN¥0.12 (vs CN¥0.19 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.12 (down from CN¥0.19 in 2Q 2023). Revenue: CN¥740.3m (up 3.4% from 2Q 2023). Net income: CN¥60.3m (down 41% from 2Q 2023). Profit margin: 8.1% (down from 14% in 2Q 2023). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings.New Risk • Jul 22New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 9.2% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (9.2% average weekly change). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (3.6% net profit margin).お知らせ • Jul 11PhiChem Corporation Announces Final Dividend on A Shares for the Year 2023, Payable on July 16, 2024PhiChem Corporation announced final cash dividend/10 shares (tax included) of CNY 0.80000000 on A shares for the year 2023. Record date is July 15, 2024. Ex-date is July 16, 2024. Payment date is July 16, 2024.お知らせ • Jun 29PhiChem Corporation to Report First Half, 2024 Results on Aug 30, 2024PhiChem Corporation announced that they will report first half, 2024 results on Aug 30, 2024Valuation Update With 7 Day Price Move • Jun 26Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥12.32, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 32% over the past three years.Valuation Update With 7 Day Price Move • Jun 11Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥13.36, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 17% over the past three years.Reported Earnings • Apr 30First quarter 2024 earnings released: EPS: CN¥0.11 (vs CN¥0.14 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.11 (down from CN¥0.14 in 1Q 2023). Revenue: CN¥668.5m (up 11% from 1Q 2023). Net income: CN¥59.8m (down 17% from 1Q 2023). Profit margin: 9.0% (down from 12% in 1Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 25% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings.お知らせ • Apr 30PhiChem Corporation, Annual General Meeting, May 21, 2024PhiChem Corporation, Annual General Meeting, May 21, 2024, at 14:30 China Standard Time. Location: The Company's Meeting Room, Shanghai Chinaお知らせ • Mar 30PhiChem Corporation to Report Q1, 2024 Results on Apr 29, 2024PhiChem Corporation announced that they will report Q1, 2024 results on Apr 29, 2024Valuation Update With 7 Day Price Move • Mar 26Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥12.09, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 19% over the past three years.Valuation Update With 7 Day Price Move • Mar 04Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥14.84, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 2.4% over the past three years.Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥11.26, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 20% over the past three years.お知らせ • Dec 30PhiChem Corporation to Report Fiscal Year 2023 Results on Mar 30, 2024PhiChem Corporation announced that they will report fiscal year 2023 results on Mar 30, 2024Valuation Update With 7 Day Price Move • Oct 31Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥17.70, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 5.2% over the past three years.New Risk • Oct 30New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.Reported Earnings • Oct 25Third quarter 2023 earnings released: EPS: CN¥0.069 (vs CN¥0.13 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.069 (down from CN¥0.13 in 3Q 2022). Revenue: CN¥708.6m (up 19% from 3Q 2022). Net income: CN¥36.0m (down 47% from 3Q 2022). Profit margin: 5.1% (down from 11% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.Reported Earnings • Aug 25Second quarter 2023 earnings released: EPS: CN¥0.19 (vs CN¥0.22 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.19 (down from CN¥0.22 in 2Q 2022). Revenue: CN¥715.8m (down 8.1% from 2Q 2022). Net income: CN¥102.0m (down 11% from 2Q 2022). Profit margin: 14% (in line with 2Q 2022). Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings.New Risk • Aug 23New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 0.5% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. This is currently the only risk that has been identified for the company.Board Change • Jun 25High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Non-Independent Director Deqing Meng was the last director to join the board, commencing their role in 2023. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.お知らせ • May 30PhiChem Corporation Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 02 June 2023PhiChem Corporation announced final profit distribution plan to be implemented on A shares as cash dividend per ten shares (tax included) of CNY 0.80000000 for the year 2022, payable on 02 June 2023. Record date is 01 June 2023. Ex-date is 02 June 2023.Reported Earnings • Apr 28First quarter 2023 earnings released: EPS: CN¥0.14 (vs CN¥0.27 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.14 (down from CN¥0.27 in 1Q 2022). Revenue: CN¥601.7m (down 31% from 1Q 2022). Net income: CN¥72.4m (down 48% from 1Q 2022). Profit margin: 12% (down from 16% in 1Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. No highly experienced directors. Non Executive Director Yongjun Li was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.Reported Earnings • Oct 27Third quarter 2022 earnings released: EPS: CN¥0.13 (vs CN¥0.20 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.13 (down from CN¥0.20 in 3Q 2021). Revenue: CN¥595.3m (down 13% from 3Q 2021). Net income: CN¥67.8m (down 34% from 3Q 2021). Profit margin: 11% (down from 15% in 3Q 2021). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth.Reported Earnings • Aug 27Second quarter 2022 earnings released: EPS: CN¥0.22 (vs CN¥0.20 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.22 (up from CN¥0.20 in 2Q 2021). Revenue: CN¥779.1m (up 22% from 2Q 2021). Net income: CN¥114.3m (up 14% from 2Q 2021). Profit margin: 15% (in line with 2Q 2021). Over the next year, revenue is forecast to grow 12%, compared to a 39% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth.Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. No highly experienced directors. Non Executive Director Yongjun Li was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.Reported Earnings • Apr 03Full year 2021 earnings released: EPS: CN¥0.75 (vs CN¥0.45 in FY 2020)Full year 2021 results: EPS: CN¥0.75 (up from CN¥0.45 in FY 2020). Revenue: CN¥2.63b (up 41% from FY 2020). Net income: CN¥385.9m (up 68% from FY 2020). Profit margin: 15% (up from 12% in FY 2020). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 21%, compared to a 48% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has increased by 18% per year, which means it is tracking significantly ahead of earnings growth.Board Change • Apr 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. No highly experienced directors. Non Executive Director Yongjun Li was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.Valuation Update With 7 Day Price Move • Mar 01Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥28.00, the stock trades at a forward P/E ratio of 37x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 85% over the past three years.Valuation Update With 7 Day Price Move • Jan 22Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to CN¥26.40, the stock trades at a forward P/E ratio of 35x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 98% over the past three years.Valuation Update With 7 Day Price Move • Jan 05Investor sentiment improved over the past weekAfter last week's 21% share price gain to CN¥26.45, the stock trades at a forward P/E ratio of 37x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 104% over the past three years.Reported Earnings • Oct 31Third quarter 2021 earnings released: EPS CN¥0.20 (vs CN¥0.12 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥684.3m (up 33% from 3Q 2020). Net income: CN¥102.4m (up 73% from 3Q 2020). Profit margin: 15% (up from 12% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings.Reported Earnings • Aug 11Second quarter 2021 earnings released: EPS CN¥0.20 (vs CN¥0.12 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥639.6m (up 39% from 2Q 2020). Net income: CN¥99.8m (up 72% from 2Q 2020). Profit margin: 16% (up from 13% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.Reported Earnings • Apr 29First quarter 2021 earnings released: EPS CN¥0.13 (vs CN¥0.10 in 1Q 2020)The company reported a solid first quarter result with improved earnings and revenues, although profit margins were weaker. First quarter 2021 results: Revenue: CN¥562.9m (up 53% from 1Q 2020). Net income: CN¥68.2m (up 30% from 1Q 2020). Profit margin: 12% (down from 14% in 1Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has fallen by 9% per year, which means it is performing significantly worse than earnings.Reported Earnings • Mar 18Full year 2020 earnings released: EPS CN¥0.45 (vs CN¥0.50 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: CN¥1.86b (up 23% from FY 2019). Net income: CN¥229.8m (down 9.9% from FY 2019). Profit margin: 12% (down from 17% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.Is New 90 Day High Low • Jan 26New 90-day low: CN¥16.20The company is down 20% from its price of CN¥20.17 on 29 October 2020. The Chinese market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 24% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥1.43 per share.Is New 90 Day High Low • Dec 12New 90-day low: CN¥17.90The company is down 10.0% from its price of CN¥19.88 on 11 September 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥1.14 per share.Reported Earnings • Oct 29Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥240.3m, up 12% from the prior year. Total revenue was CN¥1.75b over the last 12 months, up 20% from the prior year.収支内訳PhiChem の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史XSEC:300398 収益、費用、利益 ( )CNY Millions日付収益収益G+A経費研究開発費31 Dec 253,22639046620930 Sep 253,08933245619430 Jun 252,97134343418531 Mar 252,95030646817631 Dec 242,91824746518230 Sep 242,90110851718030 Jun 242,8365852818731 Mar 242,79510046619331 Dec 232,72911245918930 Sep 232,66632439717230 Jun 232,56335636016531 Mar 232,64336837517501 Jan 232,90743539818430 Sep 222,98043638821030 Jun 223,06947139621631 Mar 222,93045638120201 Jan 222,62738634519330 Sep 212,40633132516630 Jun 212,23728831015531 Mar 212,05924630615531 Dec 201,86423027713630 Sep 201,74624029814430 Jun 201,59624328213231 Mar 201,50923426212131 Dec 191,51325526712230 Sep 191,45721423710930 Jun 191,44925122011331 Mar 191,45928521711531 Dec 181,44628422211430 Sep 181,44328925212730 Jun 181,31421521614131 Mar 181,07014220510731 Dec 17820841738430 Sep 17578641074530 Jun 1744556126031 Mar 1740065114031 Dec 1639168113030 Sep 1638775112030 Jun 1640890105031 Mar 1642698100031 Dec 1543210595030 Sep 1545710690030 Jun 15447104850質の高い収益: 300398は 高品質の収益 を持っています。利益率の向上: 300398の現在の純利益率 (12.1%)は、昨年(8.4%)よりも高くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: 300398の収益は過去 5 年間で年間5.6%減少しました。成長の加速: 300398の過去 1 年間の収益成長率 ( 58.4% ) は、5 年間の平均 ( 年間-5.6%を上回っています。収益対業界: 300398の過去 1 年間の収益成長率 ( 58.4% ) はChemicals業界3.7%を上回りました。株主資本利益率高いROE: 300398の 自己資本利益率 ( 8.1% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/10 20:46終値2026/06/10 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋PhiChem Corporation 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。9 アナリスト機関Xiongwei JiaChina International Capital Corporation LimitedKai LiuEverbright Securities Co. Ltd.Wei LiuHaitong International Research Limited6 その他のアナリストを表示
お知らせ • Mar 31PhiChem Corporation to Report Q1, 2026 Results on Apr 22, 2026PhiChem Corporation announced that they will report Q1, 2026 results on Apr 22, 2026
お知らせ • Dec 31PhiChem Corporation to Report Fiscal Year 2025 Results on Apr 22, 2026PhiChem Corporation announced that they will report fiscal year 2025 results on Apr 22, 2026
お知らせ • Sep 30PhiChem Corporation to Report Q3, 2025 Results on Oct 30, 2025PhiChem Corporation announced that they will report Q3, 2025 results on Oct 30, 2025
お知らせ • Jul 02PhiChem Corporation to Report First Half, 2025 Results on Aug 28, 2025PhiChem Corporation announced that they will report first half, 2025 results on Aug 28, 2025
お知らせ • Mar 31PhiChem Corporation to Report Q1, 2025 Results on Apr 23, 2025PhiChem Corporation announced that they will report Q1, 2025 results on Apr 23, 2025
お知らせ • Dec 31PhiChem Corporation to Report Fiscal Year 2024 Results on Apr 23, 2025PhiChem Corporation announced that they will report fiscal year 2024 results on Apr 23, 2025
Valuation Update With 7 Day Price Move • Jun 08Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥41.23, the stock trades at a forward P/E ratio of 39x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 146% over the past three years.
お知らせ • Apr 22PhiChem Corporation, Annual General Meeting, May 12, 2026PhiChem Corporation, Annual General Meeting, May 12, 2026, at 14:30 China Standard Time. Location: The Company's Meeting Room, Shanghai China
お知らせ • Mar 31PhiChem Corporation to Report Q1, 2026 Results on Apr 22, 2026PhiChem Corporation announced that they will report Q1, 2026 results on Apr 22, 2026
お知らせ • Dec 31PhiChem Corporation to Report Fiscal Year 2025 Results on Apr 22, 2026PhiChem Corporation announced that they will report fiscal year 2025 results on Apr 22, 2026
お知らせ • Sep 30PhiChem Corporation to Report Q3, 2025 Results on Oct 30, 2025PhiChem Corporation announced that they will report Q3, 2025 results on Oct 30, 2025
お知らせ • Jul 02PhiChem Corporation to Report First Half, 2025 Results on Aug 28, 2025PhiChem Corporation announced that they will report first half, 2025 results on Aug 28, 2025
お知らせ • May 22PhiChem Corporation Approves Cash Dividend for 2024PhiChem Corporation held its Annual General Meeting of 2024 on 16 May 2025, approved cash dividend/10 shares (tax included): CNY 0.65000000 for 2024.
お知らせ • Apr 25PhiChem Corporation Proposes Final Cash Dividend for the Year 2024PhiChem Corporation proposed final cash dividend/10 shares (tax included) of CNY 0.65000000 for the year 2024.
お知らせ • Apr 23PhiChem Corporation, Annual General Meeting, May 16, 2025PhiChem Corporation, Annual General Meeting, May 16, 2025, at 14:30 China Standard Time. Location: The Company's Meeting Room, Shanghai China
お知らせ • Mar 31PhiChem Corporation to Report Q1, 2025 Results on Apr 23, 2025PhiChem Corporation announced that they will report Q1, 2025 results on Apr 23, 2025
お知らせ • Mar 22Shenmao Technology Inc (TWSE:3305) completed the acquisition of Profound Material Technology Co., Ltd. from PhiChem Corporation (SZSE:300398).Shenmao Technology Inc (TWSE:3305) signed a letter of intent to acquire Profound Material Technology Co., Ltd. from PhiChem Corporation (SZSE:300398) for approximately CNY 230 million on September 27, 2024. Profound Material Technology Co., Ltd. had reported total assets of CNY 127.176 million, total owner’s equity of CNY 99.815 million, revenue of CNY 99.6654 million, operating profit of CNY 13.1983 million and net profit of CNY 10.5306 million on December 31, 2023. The transaction is subject to approval of offer by acquirer board. The deal has been approved by the board of Shenmao Technology Inc. Transaction has been approved by PhiChem Corporation's Board of director's and is still subject to approval from PhiChem Corporation's shareholders. As on January 6, 2025, PhiChem Corporation and Shenmao Technology signed the Share Purchase and Sale Agreement. Transaction is expected to complete on March 20, 2025. Shenmao Technology Inc (TWSE:3305) completed the acquisition of Profound Material Technology Co., Ltd. from PhiChem Corporation (SZSE:300398) on March 20, 2025.
お知らせ • Dec 31PhiChem Corporation to Report Fiscal Year 2024 Results on Apr 23, 2025PhiChem Corporation announced that they will report fiscal year 2024 results on Apr 23, 2025
お知らせ • Dec 21PhiChem Corporation Announces Third Quarter 2024 Profit Distribution, Payable on 27 December 2024PhiChem Corporation announced 2024 third quarter profit distribution plan to be implemented (A shares): Cash dividend per 10 shares (tax included) of CNY 0.30000000. Record date: 26 December 2024; Ex-date: 27 December 2024; Payment date: 27 December 2024.
お知らせ • Oct 30PhiChem Corporation Proposes Cash Dividend for the Third Quarter of 2024PhiChem Corporation announced on 29 October 2024 the profit distribution proposal for the third quarter of 2024 as follows: Cash dividend/10 shares (tax included) of CNY 0.30000000.
Reported Earnings • Oct 29Third quarter 2024 earnings released: EPS: CN¥0.16 (vs CN¥0.069 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.16 (up from CN¥0.069 in 3Q 2023). Revenue: CN¥762.0m (up 7.5% from 3Q 2023). Net income: CN¥85.7m (up 138% from 3Q 2023). Profit margin: 11% (up from 5.1% in 3Q 2023). Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings.
お知らせ • Sep 30PhiChem Corporation to Report Q3, 2024 Results on Oct 29, 2024PhiChem Corporation announced that they will report Q3, 2024 results on Oct 29, 2024
Reported Earnings • Aug 30Second quarter 2024 earnings released: EPS: CN¥0.12 (vs CN¥0.19 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.12 (down from CN¥0.19 in 2Q 2023). Revenue: CN¥740.3m (up 3.4% from 2Q 2023). Net income: CN¥60.3m (down 41% from 2Q 2023). Profit margin: 8.1% (down from 14% in 2Q 2023). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings.
New Risk • Jul 22New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 9.2% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (9.2% average weekly change). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (3.6% net profit margin).
お知らせ • Jul 11PhiChem Corporation Announces Final Dividend on A Shares for the Year 2023, Payable on July 16, 2024PhiChem Corporation announced final cash dividend/10 shares (tax included) of CNY 0.80000000 on A shares for the year 2023. Record date is July 15, 2024. Ex-date is July 16, 2024. Payment date is July 16, 2024.
お知らせ • Jun 29PhiChem Corporation to Report First Half, 2024 Results on Aug 30, 2024PhiChem Corporation announced that they will report first half, 2024 results on Aug 30, 2024
Valuation Update With 7 Day Price Move • Jun 26Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥12.32, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 32% over the past three years.
Valuation Update With 7 Day Price Move • Jun 11Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥13.36, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 17% over the past three years.
Reported Earnings • Apr 30First quarter 2024 earnings released: EPS: CN¥0.11 (vs CN¥0.14 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.11 (down from CN¥0.14 in 1Q 2023). Revenue: CN¥668.5m (up 11% from 1Q 2023). Net income: CN¥59.8m (down 17% from 1Q 2023). Profit margin: 9.0% (down from 12% in 1Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 25% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings.
お知らせ • Apr 30PhiChem Corporation, Annual General Meeting, May 21, 2024PhiChem Corporation, Annual General Meeting, May 21, 2024, at 14:30 China Standard Time. Location: The Company's Meeting Room, Shanghai China
お知らせ • Mar 30PhiChem Corporation to Report Q1, 2024 Results on Apr 29, 2024PhiChem Corporation announced that they will report Q1, 2024 results on Apr 29, 2024
Valuation Update With 7 Day Price Move • Mar 26Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥12.09, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 19% over the past three years.
Valuation Update With 7 Day Price Move • Mar 04Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥14.84, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 2.4% over the past three years.
Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥11.26, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 20% over the past three years.
お知らせ • Dec 30PhiChem Corporation to Report Fiscal Year 2023 Results on Mar 30, 2024PhiChem Corporation announced that they will report fiscal year 2023 results on Mar 30, 2024
Valuation Update With 7 Day Price Move • Oct 31Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥17.70, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 5.2% over the past three years.
New Risk • Oct 30New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
Reported Earnings • Oct 25Third quarter 2023 earnings released: EPS: CN¥0.069 (vs CN¥0.13 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.069 (down from CN¥0.13 in 3Q 2022). Revenue: CN¥708.6m (up 19% from 3Q 2022). Net income: CN¥36.0m (down 47% from 3Q 2022). Profit margin: 5.1% (down from 11% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.
Reported Earnings • Aug 25Second quarter 2023 earnings released: EPS: CN¥0.19 (vs CN¥0.22 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.19 (down from CN¥0.22 in 2Q 2022). Revenue: CN¥715.8m (down 8.1% from 2Q 2022). Net income: CN¥102.0m (down 11% from 2Q 2022). Profit margin: 14% (in line with 2Q 2022). Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings.
New Risk • Aug 23New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 0.5% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. This is currently the only risk that has been identified for the company.
Board Change • Jun 25High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Non-Independent Director Deqing Meng was the last director to join the board, commencing their role in 2023. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
お知らせ • May 30PhiChem Corporation Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 02 June 2023PhiChem Corporation announced final profit distribution plan to be implemented on A shares as cash dividend per ten shares (tax included) of CNY 0.80000000 for the year 2022, payable on 02 June 2023. Record date is 01 June 2023. Ex-date is 02 June 2023.
Reported Earnings • Apr 28First quarter 2023 earnings released: EPS: CN¥0.14 (vs CN¥0.27 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.14 (down from CN¥0.27 in 1Q 2022). Revenue: CN¥601.7m (down 31% from 1Q 2022). Net income: CN¥72.4m (down 48% from 1Q 2022). Profit margin: 12% (down from 16% in 1Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. No highly experienced directors. Non Executive Director Yongjun Li was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
Reported Earnings • Oct 27Third quarter 2022 earnings released: EPS: CN¥0.13 (vs CN¥0.20 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.13 (down from CN¥0.20 in 3Q 2021). Revenue: CN¥595.3m (down 13% from 3Q 2021). Net income: CN¥67.8m (down 34% from 3Q 2021). Profit margin: 11% (down from 15% in 3Q 2021). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Aug 27Second quarter 2022 earnings released: EPS: CN¥0.22 (vs CN¥0.20 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.22 (up from CN¥0.20 in 2Q 2021). Revenue: CN¥779.1m (up 22% from 2Q 2021). Net income: CN¥114.3m (up 14% from 2Q 2021). Profit margin: 15% (in line with 2Q 2021). Over the next year, revenue is forecast to grow 12%, compared to a 39% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth.
Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. No highly experienced directors. Non Executive Director Yongjun Li was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
Reported Earnings • Apr 03Full year 2021 earnings released: EPS: CN¥0.75 (vs CN¥0.45 in FY 2020)Full year 2021 results: EPS: CN¥0.75 (up from CN¥0.45 in FY 2020). Revenue: CN¥2.63b (up 41% from FY 2020). Net income: CN¥385.9m (up 68% from FY 2020). Profit margin: 15% (up from 12% in FY 2020). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 21%, compared to a 48% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has increased by 18% per year, which means it is tracking significantly ahead of earnings growth.
Board Change • Apr 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. No highly experienced directors. Non Executive Director Yongjun Li was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Mar 01Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥28.00, the stock trades at a forward P/E ratio of 37x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 85% over the past three years.
Valuation Update With 7 Day Price Move • Jan 22Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to CN¥26.40, the stock trades at a forward P/E ratio of 35x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 98% over the past three years.
Valuation Update With 7 Day Price Move • Jan 05Investor sentiment improved over the past weekAfter last week's 21% share price gain to CN¥26.45, the stock trades at a forward P/E ratio of 37x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 104% over the past three years.
Reported Earnings • Oct 31Third quarter 2021 earnings released: EPS CN¥0.20 (vs CN¥0.12 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥684.3m (up 33% from 3Q 2020). Net income: CN¥102.4m (up 73% from 3Q 2020). Profit margin: 15% (up from 12% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings.
Reported Earnings • Aug 11Second quarter 2021 earnings released: EPS CN¥0.20 (vs CN¥0.12 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥639.6m (up 39% from 2Q 2020). Net income: CN¥99.8m (up 72% from 2Q 2020). Profit margin: 16% (up from 13% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.
Reported Earnings • Apr 29First quarter 2021 earnings released: EPS CN¥0.13 (vs CN¥0.10 in 1Q 2020)The company reported a solid first quarter result with improved earnings and revenues, although profit margins were weaker. First quarter 2021 results: Revenue: CN¥562.9m (up 53% from 1Q 2020). Net income: CN¥68.2m (up 30% from 1Q 2020). Profit margin: 12% (down from 14% in 1Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has fallen by 9% per year, which means it is performing significantly worse than earnings.
Reported Earnings • Mar 18Full year 2020 earnings released: EPS CN¥0.45 (vs CN¥0.50 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: CN¥1.86b (up 23% from FY 2019). Net income: CN¥229.8m (down 9.9% from FY 2019). Profit margin: 12% (down from 17% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.
Is New 90 Day High Low • Jan 26New 90-day low: CN¥16.20The company is down 20% from its price of CN¥20.17 on 29 October 2020. The Chinese market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 24% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥1.43 per share.
Is New 90 Day High Low • Dec 12New 90-day low: CN¥17.90The company is down 10.0% from its price of CN¥19.88 on 11 September 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥1.14 per share.
Reported Earnings • Oct 29Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥240.3m, up 12% from the prior year. Total revenue was CN¥1.75b over the last 12 months, up 20% from the prior year.